146 related articles for article (PubMed ID: 4419015)
1. [Free and combined protease inhibitors in bronchial mucus in patients with extended chronic obstructive airway diseases (author's transl)].
Hochstrasser K; Rasche B; Reichert R; Hochgesand K
Pneumonologie; 1974; 150(2-4):253-9. PubMed ID: 4419015
[No Abstract] [Full Text] [Related]
2. [Inter-alpha-trypsin inhibitor in serum and bronchial mucus inhibitor in sputum in chronic airway obstruction (author's transl)].
Rasche B; Hochstrasser K; Ulmer WT
Respiration; 1978; 36(1):39-47. PubMed ID: 307266
[No Abstract] [Full Text] [Related]
3. [Elastase and elastase inhibitors in bronchial mucus in chronic airway obstruction with reference to therapy].
Rasche B; Hochstrasser K
Prax Klin Pneumol; 1983 Oct; 37 Suppl 1():725-7. PubMed ID: 6557570
[No Abstract] [Full Text] [Related]
4. Inhibitor activity against elastolytic enzymes in the bronchial area. A contribution to the pathogenesis of chronic airway obstruction.
Rasche B
Z Erkr Atmungsorgane; 1985; 165(1):83-93. PubMed ID: 3851611
[TBL] [Abstract][Full Text] [Related]
5. Characterization of masked specific proteinase inhibitor from bronchial secretions in purulent sputum as complex with leucocytic proteinases.
Hochstrasser K; Schorn K; Rasche B; Lemparth K; Raffelt Ch
Pneumonologie; 1975 Sep; 152(1-3):15-24. PubMed ID: 1187387
[No Abstract] [Full Text] [Related]
6. [Mucous membrane specific protease inhibitors in bronchial mucus in severe chronic obstructive bronchitis and in alpha 1-antitrypsin deficiency syndrome].
Rasche B; Hochstrasser K; Marcic I; Ulmer WT
Respiration; 1975; 32(5):340-54. PubMed ID: 1080869
[TBL] [Abstract][Full Text] [Related]
7. [Concentration of low-molecular protease inhibitor in the bronchial secretion in 1 -antitrypsin deficiency].
Reichert R; Hochstrasser K; Fruhmann G; Fritz H; Werle E
Pneumonologie; 1972; 147(1):41-5. PubMed ID: 5083260
[No Abstract] [Full Text] [Related]
8. [Demonstration of a low-molecular protease inhibitor in human bronchial secretion].
Reichert R; Hochstrasser K; Werle E
Z Laryngol Rhinol Otol; 1972 Mar; 51(3):190-3. PubMed ID: 5027523
[No Abstract] [Full Text] [Related]
9. [Protease inhibitors from lung, secretions and blood in horses and cattle: a comparative study on endogenous, predisposing factors of chronic obstructive lung disease].
von Fellenberg R; Minder H; Wegmann C; Frei F
Schweiz Arch Tierheilkd; 1979 Jul; 121(7):355-65. PubMed ID: 482922
[No Abstract] [Full Text] [Related]
10. [About the question of simultaneously occuring proteolytic and antiproteolytic activity in sputum in case of obstructive airway diseases (author's transl)].
Hochstrasser K; Hochgesand K; Rasche B
Respiration; 1974; 31(4):343-9. PubMed ID: 4842829
[No Abstract] [Full Text] [Related]
11. [Possibilities for inactivation of protease activity in sputum by protease inhibitors in chronic obstructive airway diseases].
Rasche B; Ulmer WT
Res Exp Med (Berl); 1972; 158(3):229-45. PubMed ID: 4117560
[No Abstract] [Full Text] [Related]
12. Benzo(a)pyrene hydroxylase activity in human bronchial mucus.
Kapoor A; Batra JK; Luthra UK; Jain RC; Venkitasubramanian TA; Raj HG
Eur J Drug Metab Pharmacokinet; 1986; 11(1):33-7. PubMed ID: 3087751
[TBL] [Abstract][Full Text] [Related]
13. [The "IgA secretory component complex" in bronchial mucus in patients with chronic obstructive lung disease under different therapy (author's transl)].
Rasche B; Curschmann P
Respiration; 1979; 37(2):97-108. PubMed ID: 87005
[TBL] [Abstract][Full Text] [Related]
14. [Identification and characterization of proteins from human bronchial secretion (author's transl)].
Laine A; Hayem A
Clin Chim Acta; 1976 Mar; 67(2):159-67. PubMed ID: 1248152
[TBL] [Abstract][Full Text] [Related]
15. The importance of lysozyme for the viscosity of sputum from patients with chronic obstructive lung disease.
Jenssen AO; Smidsrød O; Harbitz O
Scand J Clin Lab Invest; 1980; 40(8):727-31. PubMed ID: 7280551
[TBL] [Abstract][Full Text] [Related]
16. The biochemical pathogenesis of chronic obstructive pulmonary diseases: protease-antiprotease imbalance in emphysema and diseases of the airways.
Kuhn C
J Thorac Imaging; 1986 Mar; 1(2):1-6. PubMed ID: 3298671
[TBL] [Abstract][Full Text] [Related]
17. [Antiproteases of bronchial mucus].
Lebas J; Laine A; Hayem A
Lille Med; 1976 Feb; 21(2):136-9. PubMed ID: 950872
[No Abstract] [Full Text] [Related]
18. [The protease-inhibitor capacity of human bronchial mucus. Content in low molecular inhibitor and 1 -antitrypsin under physiological and physiopathological conditions].
Reichert R; Hochstrasser K; Conradi G
Pneumonologie; 1972; 147(1):13-20. PubMed ID: 5083256
[No Abstract] [Full Text] [Related]
19. [Respiratory function and the rheological status of bronchial secretions collected by spontaneous expectoration and after physiotherapy (author's transl)].
Pham QT; Peslin R; Puchelle E; Salmon D; Caraux G; Benis AM
Bull Physiopathol Respir (Nancy); 1973; 9(2):293-314. PubMed ID: 4778953
[No Abstract] [Full Text] [Related]
20. [Inhibitors of proteases in bronchial secretion of patients deficient in alpha-l-antitrypsin].
Laine A; Lebas J; Hayem A
Lille Med; 1976 Feb; 21(2):140-3. PubMed ID: 1084948
[No Abstract] [Full Text] [Related]
[Next] [New Search]
